17 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
. We are considering lab options commensurate with the start of the Phase II trials and dose escalation study.
Employees and Human Capital Resources … bargaining agreement or represented by a trade or labor union. We consider our relationship with our employees to be good.
Our human capital resources
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
. We are considering lab options commensurate with the start of the Phase II trials and dose escalation study.
Employees and Human Capital Resources … bargaining agreement or represented by a trade or labor union. We consider our relationship with our employees to be good.
Our human capital resources
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
are considering lab options commensurate with the start of the Phase II trials and dose escalation study.
Employees and Human Capital Resources … agreement or represented by a trade or labor union. We consider our relationship with our employees to be good.
Our human capital resources
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:30pm
of the Phase II trials and dose escalation study.
Employees and Human Capital Resources
As of January 1, 2024, we had three full-time employees … . We consider our relationship with our employees to be good.
Our human capital resources objectives include, as applicable, identifying, recruiting
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:28pm
trials and dose escalation study.
Employees and Human Capital Resources
As of January 1, 2024, we had three full-time employees and four … our relationship with our employees to be good.
Our human capital resources objectives include, as applicable, identifying, recruiting, retaining
DRS/A
yp0tjy
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next